In New York, genomic data analysis platforms from Seven Bridges and SolveBio have been integrated with each other to provide expanded capabilities to clients. While financial terms of the agreement were not publicly available, Seven Bridges raised $45 million and SolveBio raised $4.5 million in financing earlier this year. The Seven Bridges platform allows the analysis of millions of genomes with other data. Their clients include the Children’s Hospital of Philadelphia, the VA’s Million Veteran Program, and the National Cancer Institute. SolveBio’s platform allows the indexing and linking of biomarkers and variant data. Now with both platforms integrated, clients can analyze large genomic datasets using Seven Bridges and connect that information to SolveBio for interpretation and assessments.
Latest article
Body-based burial: Students imagine urns made from blood and hair
In Slovenia, students at University of Ljubljana have used biobased materials for a variety of design projects, including a biodegradable urn made of blood...
Uttar Pradesh eyes cow poop plastics to boost rural economy
In Uttar Pradesh, a government project is collecting cow dung to convert into usable products such as bioplastics, textiles, and paper.
The Press Trust...
Luxury brand Velvet Eyewear lauds advances in biobased acetate
In California, luxury women’s eyewear brand Velvet Eyewear has unveiled its first biobased eyewear collection.
Crafted from renewable sources like wood pulp and cotton...